Cameron Durrant - 30 Sep 2021 Form 4 Insider Report for HUMANIGEN, INC

Role
Chief Executive Officer, Director
Signature
/s/ Cameron Durrant
Issuer symbol
N/A
Transactions as of
30 Sep 2021
Net transactions value
$0
Form type
4
Filing time
04 Oct 2021, 20:07:11 UTC
Previous filing
16 Jun 2021
Next filing
26 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HGEN Stock Option (Right to Buy) Award $0 +17,660 $0.000000 17,660 30 Sep 2021 Common Stock 17,660 $5.93 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option was granted to the reporting person in lieu of 50% of his base salary for the fourth quarter of 2021. The option vests in three ratable installments on each of October 31, 2021, November 30, 2021 and December 31, 2021.